Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: Association with disease severity and delayed mycobacterial clearance with treatment

Simple item page
dc.contributor.authorRalph, Anna P
dc.contributor.authorYeo, Tsin W.
dc.contributor.authorSalome, Cheryl
dc.contributor.authorWaramori, G
dc.contributor.authorPontororing, Gysje J
dc.contributor.authorKenangalem, Enny
dc.contributor.authorSandjaja, .
dc.contributor.authorTjitra, Emiliana
dc.contributor.authorLumb, Richard
dc.contributor.authorMaguire, Graeme P.
dc.contributor.authorPrice, Ric N
dc.contributor.authorChatfield, Mark D
dc.contributor.authorKelly, Paul
dc.contributor.authorAnstey, Nicholas
dc.date.accessioned2015-12-13T22:27:37Z
dc.date.issued2013
dc.date.updated2016-02-24T09:19:00Z
dc.description.abstractBackground. Nitric oxide (NO), a key macrophage antimycobacterial mediator that ameliorates immunopathology, is measurable in exhaled breath in individuals with pulmonary tuberculosis. We investigated relationships between fractional exhale NO (FENO) and
dc.identifier.issn1201-9712
dc.identifier.urihttp://hdl.handle.net/1885/74015
dc.publisherElsevier
dc.sourceInternational Journal of Infectious diseases
dc.subjectKeywords: arginine; nitric oxide; vitamin D; adolescent; adult; aged; article; bacterial clearance; controlled study; disease association; disease severity; female; follow up; forced vital capacity; human; lung tuberculosis; major clinical study; male; Papua New Gu Biomarker; Exhaled nitric oxide; L-arginine; M2 macrophages; Tuberculosis
dc.titleImpaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: Association with disease severity and delayed mycobacterial clearance with treatment
dc.typeJournal article
local.bibliographicCitation.issue4
local.bibliographicCitation.lastpage626
local.bibliographicCitation.startpage616
local.contributor.affiliationRalph, Anna P, Charles Darwin University
local.contributor.affiliationYeo, Tsin W., Charles Darwin University
local.contributor.affiliationSalome, Cheryl, University of Sydney
local.contributor.affiliationWaramori, G, Public Health & Malaria Control Department
local.contributor.affiliationPontororing, Gysje J, National Institute of Health Research and Development Research Program
local.contributor.affiliationKenangalem, Enny, Menzies School of Health Research
local.contributor.affiliationSandjaja, ., National Institute of Health Research and Development
local.contributor.affiliationTjitra, Emiliana, Ministry of Health, Indonesia
local.contributor.affiliationLumb, Richard, Institute of Medical and Veterinary Science
local.contributor.affiliationMaguire, Graeme P., James Cook University
local.contributor.affiliationPrice, Ric N, Charles Darwin University
local.contributor.affiliationChatfield, Mark D, Charles Darwin University
local.contributor.affiliationKelly, Paul, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationAnstey, Nicholas, Menzies School of Health Research
local.contributor.authoruidKelly, Paul, u4323806
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor060500 - MICROBIOLOGY
local.identifier.ariespublicationf5625xPUB3931
local.identifier.citationvolume208
local.identifier.doi10.1093/infdis/jit248
local.identifier.scopusID2-s2.0-84880934841
local.identifier.thomsonID000322412100011
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Ralph_Impaired_pulmonary_nitric_2013.pdf
Size:
748 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS